Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos.
Popular Articles

Z-Cube And Yissum Research Development Company Ltd. Sign A Licensing Agreement
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain. The technology was invented by Professor Elka Touitou from the Department of Pharmaceutics, Faculty of Medicine, at the Hebrew University of Jerusalem.
pharmacy online
Ascenta Therapeutics Announces Multiple Presentations On AT-101 At 2009 ASCO Annual Meeting
Ascenta Therapeutics announced that eleven presentations or publications on pre-clinical and clinical studies of AT-101, an oral, pan-Bcl-2 inhibitor, in several major tumor types will be made during the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June 2, in Orlando, Florida.
News of the day
Shreveport, La., Center Continues To Provide HIV/AIDS Services After 20 Years
The Shreveport Times profiled the 20-year-old Shreveport, La.-based Philadelphia Center, an agency that provides HIV/AIDS services to "an average of nearly 600 people each year in northwest Louisiana" and provides "about 1,400 free HIV tests each year." The organization also has a residential program called the Mercy Center, "a haven for homeless people with HIV or those fighting addiction and other challenges," according to the Times. The center in large part is supported by an annual auction from which proceeds "help the agency operate support groups, coordinate medical, dental and housing services for clients, provide food and medicine to people and offer free, on-the-spot HIV testing," the article states. The center recently opened a satellite office in a nearby town in response to an increase in HIV infections in the area (Brumble 8/2).
Nutrition

Cook Medical And LMA Urology Ltd Forge Global Partnership To Advance Global Treatment Of Stone Disease

Cook Medical and LMA Urology Ltd have entered into a strategic partnership that can significantly improve the remedies available for stone disease management. Through the worldwide agreement, Cook will market and distribute LMA"s StoneBreakerTM, a portable pneumatic lithotripter for stone fragmentation. The StoneBreaker is a powerful, portable, easy-to manage and cost-effective lithotripter, and will be marketed in conjunction with Cook"s own cutting-edge portfolio of stone management technologies and devices. Together, they provide urologists across the globe with highly effective, comprehensive solutions for treating kidney, ureteral and bladder stones. About 3 in 20 men and 1 in 20 women in the UK will develop a kidney stone at some point in their lifetime.[1] The number of kidney stone cases diagnosed and treated in the last 5 years has increased by 60% in the UK[2]. The LMA StoneBreaker is a proprietary device that is highly effective in the treatment of urinary stone disease. The StoneBreaker"s unique, compact, ergonomic design makes it easier to manage than comparable lithotripters, reducing the procedure time for fragmentation and removal of stones. Additionally, there is minimal probe movement during the procedure allowing for safer stone fragmentation and reduced stone migration. Powered by a cartridge of high-pressure carbon dioxide gas, the StoneBreaker delivers a higher probe-tip velocity at impact to successfully break stones in one procedure, thus eliminating the need for additional costly procedure time and patient discomfort. Dr. Abhay Rane, Consultant Urological Surgeon at East Surrey Hospital NHS Trust in the UK, notes that, "The StoneBreaker is a highly effective device in the treatment of kidney stones, by providing the ability to fragment stones safely and effectively. It is relatively inexpensive as compared to other endoscopic lithotripters, and ris completely portable, requiring no external power . Commenting on the Cook Medical partnership, Dr. Markus Haller, president of LMA Urology said, "We are delighted to have Cook Medical as our partner. The company"s vast expertise in urology, combined with its substantial marketing and sales capability will allow us to achieve global market penetration for the StoneBreaker. Together, our companies provide today"s urologists with a comprehensive solution for stone management." "We are very excited to be working with LMA, a company that continues to demonstrate product excellence and quality-focused innovation in treatment of stone disorders," said Jerry French, senior vice president and global strategic business unit leader for Cook Urology. "Together we offer an industry leading stone management technology that provides urologists worldwide with a more comprehensive approach to treat kidney, ureteral and bladder stones, minimising procedure time and improving overall patient care." References [1] NHS online, kidney stones: http://www.nhs.uk/conditions/kidney-stones/Pages/Introduction.aspx [2] Hospital Episode Statistics (HES), The NHS Information Centre for health and social care Cook Medical


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009